Zhanhui Li

发表

Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.

T. Yang, Sheng Tian, Jingrui Wang, 2021, European journal of medicinal chemistry.

Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity.

L. Luo, Xu Wang, Xiaohu Zhang, 2020, European journal of medicinal chemistry.

Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonists.

L. Luo, C. Fu, Xu Wang, 2018, European journal of medicinal chemistry.

Design, synthesis, and evaluation of novel CXCR4 antagonists based on an aminoquinoline template.

L. Luo, Xiaohu Zhang, Haikuo Ma, 2020, Bioorganic chemistry.

Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2022, Bioorganic chemistry.

Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis

Xiaohu Zhang, Hongjiang Zhang, Yangxin Li, 2019, Cell Death & Disease.

Design, Synthesis, and Characterization of Novel CXCR4 Antagonists Featuring Cyclic Amines

Sheng Tian, L. Luo, C. Fu, 2020, ChemMedChem.

Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis

Xiaohu Zhang, Hongjiang Zhang, Yangxin Li, 2019, Cell Death & Disease.

Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2023, European journal of medicinal chemistry.

Design, synthesis, evaluation and optimization of potent IRAK4 inhibitors alleviating production of inflammatory cytokines in LPS-induced SIRS model.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2023, Bioorganic chemistry.

A novel feature extraction approach based on neighborhood rough set and PCA for migraine rs-fMRI

Jiancong Fan, Leiyu Tang, Yande Ren, 2020, J. Intell. Fuzzy Syst..

Structural optimization of aminopyrimidine-based CXCR4 antagonists.

Sheng Tian, Xiaotian Sun, L. Luo, 2019, European journal of medicinal chemistry.